ClinicalTrials.gg
Not yet recruitingNCT07812714COGMOOD-TDAHUpdated Sep 10, 2026

ADHD and Mental Effort

An observational study in ADHD, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting at 1 site in France. Open to participants aged 7 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
80
Ages
7 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Attention Deficit Disorder with Hyperactivity by Assistance Publique - Hôpitaux de Paris — 7 open to participants now, 7 under way, none of them phase 3. Attention Deficit Disorder with Hyperactivity · Assistance Publique - Hôpitaux de Paris.

Started
2026
with 3 others
Observational
5 of 11
4 open now
Registered
11th of 11
by date

Among the 11 studies in Attention Deficit Disorder with Hyperactivity by Assistance Publique - Hôpitaux de Paris, this one is one of 4 that started in 2026, is one of 5 observational ones, and was the 11th registered.

Attention Deficit Disorder with Hyperactivity

1,821 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 297 are open to participants now.

Browse Attention Deficit Disorder with Hyperactivity studies →

Open to participants now

7 of the 11 studies in Attention Deficit Disorder with Hyperactivity by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 200 Attention Deficit Disorder with Hyperactivity studies recruiting now, 26 (13%) set no upper age limit and 169 (85%) stop at 75 or younger; 141 take children under 18; 55 take healthy volunteers.

This study: 7 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Attention Deficit Disorder with Hyperactivity by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

ADHD is a common childhood disorder characterised by difficulties with attention and behaviour. Various cognitive characteristics are associated with ADHD, such as executive and motivational difficulties.

Beyond these characteristics, our hypothesis is that children with ADHD may have specific strategies for allocating mental effort, influenced by motivational and metacognitive factors Our study assesses these dimensions using a behavioural task and a computational model in children with ADHD, both with and without treatment.

It aims to identify individual cognitive profiles correlated with clinical characteristics. A better understanding of the cognitive mechanisms involved in ADHD would enable the development of personalised management of the disorder.

Read the detailed description

Children hospitalized or receiving care for ADHD at the Child and Adolescent Psychiatry Department of Robert Debré Hospital will be invited to participate in the study following verification of inclusion criteria and confirmation of no parental objection.

Each participant will complete two experimental sessions, spaced 1 to 12 weeks apart, reflecting the standard follow-up and assessment schedule for children with ADHD.

If treatment is initiated during the follow-up period, at least one of the sessions will take place no more than 12 hours after a dose of medication.

Each session will include a computerized cognitive task lasting approximately one hour-assessing memory and motivation-as well as the collection of standardized clinical data (ADHD-RS diagnostic questionnaires for ADHD and DSM-5-based assessments for mental disorders).

The study does not alter standard care; it is conducted within the framework of routine clinical follow-up, involving no interruption of treatment and offering no financial benefit to participants.

03

Conditions studied

  • ADHD

Keywords

  • ADHD
  • psychiatry
  • pediatry
  • mental effort
04

Who can participate

Ages eligible
7 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Children aged between 7 years and 6 months and 18 years who have been diagnosed with ADHD and are being treated or hospitalised in the Child and Adolescent Psychiatry Department at Robert Debré Hospital, and who have not been diagnosed with ASD, an intellectual disability or a neurological condition.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with ADHD according to the criteria.
  • Receiving outpatient care or hospitalised within the Child and Adolescent
  • Psychiatry Department at Robert Debré Hospital.
  • Aged between 7 years and 6 months and under 18 years.
  • Who understand, speak and can read French.

Exclusion criteria

Exclusion Criteria:

  • Presence of ASD or an intellectual disability.
  • Presence of a neurological comorbidity, regardless of type.
  • A person with parental authority who is under guardianship or conservatorship.
  • A patient under a medical emergency authorization (AME).
  • Objection expressed by at least one parent (regardless of the form: oral, written, or other).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. group-level correlation between individual cognitive parameters (motivational and metacognitive) and individual clinical sub-scores for inattention and hyperactivity/impulsivity on the ADHDRS scale.

    To evaluate whether individual cognitive profiles derived from computational modeling explain a portion of the variability in individual clinical profiles in ADHD (inattention, hyperactivity/impulsivity).

    Time frame: 2 years

Secondary outcomes

  1. Mean within-participant difference between ADHD treatment conditions (ON vs OFF) in the computational-model-derived motivational parameter from the Memory and Stroop tasks

    To assess, at the group level, the within-participant difference between sessions with and without ADHD treatment in the individually fitted motivational parameter of the computational model. This parameter, expressed in task point-equivalents, quantifies the motivational value associated with the allocation of mental effort during the neurocognitive tasks. For each participant and session, the parameter is estimated by fitting the computational model to the participant's observed effort-allocation behavior during the Memory and Stroop tasks. The outcome reported is the group-level mean of the individual ON-versus-OFF differences in the fitted motivational parameter, expressed in task point-equivalents

    Time frame: 2 years

  2. Mean within-participant difference between ADHD treatment conditions (ON vs OFF) in the computational-model-derived metacognitive parameter from the Memory and Stroop tasks

    To assess, at the group level, the within-participant difference between sessions with and without ADHD treatment in the individually fitted metacognitive parameter of the computational model. This parameter, expressed in percent correct per second, quantifies the participant's subjective evaluation of her efficacy at making progress in the tasks, which contributes to the allocation of mental effort. For each participant and session, the parameter is estimated by fitting the computational model to the participant's observed effort-allocation behavior during the Memory and Stroop tasks. The outcome reported is the group-level mean of the individual ON-versus-OFF differences in the fitted metacognitive parameter, expressed in percent correct per second.

    Time frame: 2 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2028, 24 months later.

Of 86 non-industry observational studies under Attention Deficit Disorder with Hyperactivity, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 69. This study's planned 24 months is below that.

Counting every sponsor, half of 96 studies reached it within 35 months; a quarter within 18 and three quarters within 68.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 28, 2026
First posted
Sep 10, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Oct 1, 2028
CompletionEst.
Oct 1, 2028
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07812714
Collaborators
Paris Brain Institute (ICM)
Responsible party
Sponsor
First posted
Sep 10, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2028 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Sep 10, 2026

Study contacts

Eric ACQUAVIVA, MD
Contact
eric.acquaviva@aphp.fr
0140034092 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion